The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1

被引:20
作者
Olivieri, Kevin
Scoggins, Robert M.
Bor, Yeou-cherng
Matthews, Aprille
Mark, David
Taylor, James R., Jr.
Chernauskas, David
Hammarskjold, Marie-Louise
Rekosh, David
Camerini, David [1 ]
机构
[1] Univ Calif Irvine, Dept Biochem & Mol Biol, Ctr Immunol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Ctr Virus Res, Irvine, CA 92697 USA
[3] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA
[4] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22908 USA
关键词
R5; HIV-1; SCID-hu mice; fetal thymic organ culture; env; CCR5; thymocyte;
D O I
10.1016/j.virol.2006.08.027
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Late stage AIDS associated CCR5 tropic HIV-1 clones (R5-AIDS HIV-1) exhibit greater cytopathic effects (CPE) than earlier isolates frorn the same patients. In this study, envelopes from a series of three biological clones derived from the same patient were evaluated as a cytopathic determinant of R5-AIDS HIV-1 for thymocytes. In a single round of replication in thymocytes, the AIDS associated clone mediated greater initiation of reverse transcription. This enhancement was not due to broadened coreceptor tropism, as all clones studied were exclusively R5 tropic. The full-length R5-AIDS env mediated greater infectivity than R5 pre-AIDS em, when used to pseudotype a reporter virus. R5-AIDS env pseudotypes were more resistant to TAK-779 and showed more rapid infection kinetics but similar resistance to a CD4 blocking mAb. We conclude that the enhanced thymic replication and CPE shown by the R5-AIDS clone is due to enhanced efficiency of Env-mediated entry via CCR5. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 101 条
[71]   The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion [J].
Sackett, K ;
Shai, Y .
BIOCHEMISTRY, 2002, 41 (14) :4678-4685
[72]   Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene [J].
Samson, M ;
Libert, F ;
Doranz, BJ ;
Rucker, J ;
Liesnard, C ;
Farber, CM ;
Saragosti, S ;
Lapoumeroulie, C ;
Cognaux, J ;
Forceille, C ;
Muyldermans, G ;
Verhofstede, C ;
Burtonboy, G ;
Georges, M ;
Imai, T ;
Rana, S ;
Yi, YJ ;
Smyth, RJ ;
Collman, RG ;
Doms, RW ;
Vassart, G ;
Parmentier, M .
NATURE, 1996, 382 (6593) :722-725
[73]   In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression [J].
Scarlatti, G ;
Tresoldi, E ;
Bjorndal, A ;
Fredriksson, R ;
Colognesi, C ;
Deng, HK ;
Malnati, MS ;
Plebani, A ;
Siccardi, AG ;
Littman, DR ;
Fenyo, EM ;
Lusso, P .
NATURE MEDICINE, 1997, 3 (11) :1259-1265
[74]   BIOLOGICAL PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES AT DIFFERENT STAGES OF INFECTION - PROGRESSION OF DISEASE IS ASSOCIATED WITH A SHIFT FROM MONOCYTOTROPIC TO T-CELL-TROPIC VIRUS POPULATIONS [J].
SCHUITEMAKER, H ;
KOOT, M ;
KOOTSTRA, NA ;
DERCKSEN, MW ;
DEGOEDE, REY ;
VANSTEENWIJK, RP ;
LANGE, JMA ;
SCHATTENKERK, JKME ;
MIEDEMA, F ;
TERSMETTE, M .
JOURNAL OF VIROLOGY, 1992, 66 (03) :1354-1360
[75]   Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice [J].
Scoggins, RM ;
Taylor, JR ;
Patrie, J ;
van't Wout, AB ;
Schuitemaker, H ;
Camerini, D .
JOURNAL OF VIROLOGY, 2000, 74 (07) :3205-3216
[76]   Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation [J].
Sharma, PL ;
Crumpacker, CS .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8846-8851
[77]  
Sheppard HW, 2002, J ACQ IMMUN DEF SYND, V29, P307, DOI 10.1097/00126334-200203010-00013
[78]   The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines [J].
Srinivasakumar, N ;
Chazal, N ;
HelgaMaria, C ;
Prasad, S ;
Hammarskjold, ML ;
Rekosh, D .
JOURNAL OF VIROLOGY, 1997, 71 (08) :5841-5848
[79]  
STEIN BS, 1990, J BIOL CHEM, V265, P2640
[80]   Expression and function of chemokine receptors on human thymocytes: Implications for infection by human immunodeficiency virus type 1 [J].
Taylor, JR ;
Kimbrell, KC ;
Scoggins, R ;
Delaney, M ;
Wu, LJ ;
Camerini, D .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8752-8760